CRK1_LEIME
ID CRK1_LEIME Reviewed; 301 AA.
AC Q06309;
DT 01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-1994, sequence version 1.
DT 03-AUG-2022, entry version 97.
DE RecName: Full=Cell division protein kinase 2 homolog CRK1;
DE EC=2.7.11.23;
GN Name=CRK1;
OS Leishmania mexicana.
OC Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina;
OC Trypanosomatida; Trypanosomatidae; Leishmaniinae; Leishmania.
OX NCBI_TaxID=5665;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=MNYC/BZ/62/M379;
RX PubMed=8407941; DOI=10.1016/s0021-9258(19)36891-7;
RA Mottram J.C., Kinnaird J.H., Shiels B.R., Tait A., Barry J.D.;
RT "A novel CDC2-related protein kinase from Leishmania mexicana, LmmCRK1, is
RT post-translationally regulated during the life cycle.";
RL J. Biol. Chem. 268:21044-21052(1993).
CC -!- FUNCTION: May be involved in some stage-specific role in the
CC promastigote cell cycle.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=[DNA-directed RNA polymerase] + ATP = ADP + H(+) + phospho-
CC [DNA-directed RNA polymerase]; Xref=Rhea:RHEA:10216, Rhea:RHEA-
CC COMP:11321, Rhea:RHEA-COMP:11322, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:30616, ChEBI:CHEBI:43176, ChEBI:CHEBI:68546,
CC ChEBI:CHEBI:456216; EC=2.7.11.23;
CC -!- ACTIVITY REGULATION: Phosphorylation at Thr-15 or Tyr-16 inactivates
CC the enzyme, while phosphorylation at Thr-160 activates it.
CC {ECO:0000250}.
CC -!- SUBUNIT: Forms a stable but non-covalent complex with a regulatory
CC subunit and with a cyclin. {ECO:0000250}.
CC -!- DEVELOPMENTAL STAGE: Expressed in all life cycle stages, promastigote,
CC metacyclic and amastigote forms but is found in the active form only in
CC the promastigote stage.
CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; X60385; CAA42936.1; -; Genomic_DNA.
DR PIR; A48041; A48041.
DR AlphaFoldDB; Q06309; -.
DR SMR; Q06309; -.
DR VEuPathDB; TriTrypDB:LmxM.21.1080; -.
DR OMA; IWRIRTI; -.
DR BRENDA; 2.7.11.22; 2951.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0008353; F:RNA polymerase II CTD heptapeptide repeat kinase activity; IEA:UniProtKB-EC.
DR GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR InterPro; IPR000719; Prot_kinase_dom.
DR InterPro; IPR017441; Protein_kinase_ATP_BS.
DR InterPro; IPR008271; Ser/Thr_kinase_AS.
DR Pfam; PF00069; Pkinase; 1.
DR SMART; SM00220; S_TKc; 1.
DR SUPFAM; SSF56112; SSF56112; 1.
DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE 2: Evidence at transcript level;
KW ATP-binding; Kinase; Nucleotide-binding; Phosphoprotein;
KW Serine/threonine-protein kinase; Transferase.
FT CHAIN 1..301
FT /note="Cell division protein kinase 2 homolog CRK1"
FT /id="PRO_0000085878"
FT DOMAIN 5..297
FT /note="Protein kinase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT ACT_SITE 127
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT ECO:0000255|PROSITE-ProRule:PRU10027"
FT BINDING 11..19
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT BINDING 34
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT MOD_RES 160
FT /note="Phosphothreonine; by CAK"
FT /evidence="ECO:0000250"
SQ SEQUENCE 301 AA; 34473 MW; 58EB39D006D88461 CRC64;
MTSRYERQEK IGEGTYGVVY KARDTSTAAT VALKRIRLDS EEEGVPCTAI REISLLKELR
HENIVKLLDV CHSEHRLTIV FEYLDLDLKK YLDRENGNLD AATIQHFMRD LLRGVAFCHQ
RSVLHRDLKP QNLLISREKE LKLGDFGLGR SFAIPVRKFT NEVVTLWYRP PDVLLGSMQY
GPPVDVWSVG CIFSEMATGT PLFAGKNDAD QLMRIFRFLG TPNNRVWPSM NQYPNSNNML
SQPEFLQNFE PEWSNVLGSV PGYEKLGCAG VDLLERLLRY EPSERITAAD ALNHPYFSLQ
F